Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
shengmai san
- Development stage
- Phase 3
- Lead developer
- Tasly Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral, Intravenous
01
Overview
Shengmai San is a classic Traditional Chinese Medicine (TCM) formula composed of three primary herbs: *Panax ginseng* (Ren Shen), *Ophiopogon japonicus* (Mai Dong), and *Schisandra chinensis* (Wu Wei Zi). It is traditionally used to replenish Qi and generate fluids. In modern clinical practice, it is widely used for cardiovascular conditions, including heart failure, coronary heart disease, and preventing chemotherapy-induced cardiotoxicity. Research suggests it may also modulate gut microbiota and bile acid metabolism to improve glucose and lipid metabolism in obesity. It is available in various formulations, including decoctions, capsules, and injections (e.g., Shengmai Injection, Yiqi Fumai Lyophilized Injection).
- Brand names
- Shengmai YinShengmai InjectionShengmai CapsuleYiqi FumaiYiqi Fumai Lyophilized Injection
- Other names
- SMSShen-Mai-SanShengmai Decoction益气复脉生脉散
02
Targets
NF-κBNLRP3 (Nod-like receptor family pyrin domain-containing protein 3)
Beyond the preview
Go deeper on shengmai san.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on shengmai san.